Study on how Different Doses of Tranexamic Acid effect the blood loss in Pelviacetabular Fracture Surgery: A Randomized Clinical Trial
Not Applicable
Completed
- Conditions
- Health Condition 1: S324- Fracture of acetabulum
- Registration Number
- CTRI/2019/04/018735
- Lead Sponsor
- All India Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 32
Inclusion Criteria
1.ASA physical status 1 and 2
2.Patients undergoing surgery for pelviacetabular fracture under regional anaesthesia.
Exclusion Criteria
1.Patients with a history of severe ischaemic heart disease,
2.Patients with pulmonary embolism, deep vein thrombosis (DVT), hepatic or renal failure.
3.Patients allergic to tranexamic acid, and
4.Patients on long term anticoagulant therapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome measure: Total blood loss during intra and post operatively up to 24 hrs.Timepoint: Primary outcome measure: Total blood loss during intra and post operatively up to 24 hrs.
- Secondary Outcome Measures
Name Time Method (1)Total blood transfusion during intra and post operatively up to 24hrs. <br/ ><br>(2) Adverse effects due to tranexamic acid, Deep vein thrombosis up to 24 hrs.Timepoint: up to 24hr after surgery